Analyst EPS Estimates for Aemetis Plunge 98% Despite Biogas Project Progress
AMTX has more than doubled off its 52-week low of $1.22 on elevated volume (2.0× avg).
Summary
Analyst earnings estimates for Aemetis have plunged by approximately 98% over the past three months, with at least one analyst cutting their forecast recently. This significant negative financial outlook comes alongside operational progress, including 12 dairy digesters online, 36 miles of biogas pipeline completed, and deliveries of $27 million in equipment for its projects. This news follows the company's Q1 2026 earnings report today, which showed a 27% revenue increase and positive gross profit but also reiterated substantial doubt about its ability to continue as a going concern. A 98% reduction in analyst earnings estimates is a highly material negative development, signaling a dramatic deterioration in the market's outlook for Aemetis's future financial performance. While operational progress is positive, the severe cut in earnings expectations, especially against a backdrop of going concern warnings, will likely overshadow these developments and pressure the stock. Investors will be closely monitoring any further analyst revisions, the company's ability to address its debt obligations, and continued progress on its biogas and renewable fuels projects.
At the time of this announcement, AMTX was trading at $3.20 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $212.6M. The 52-week trading range was $1.22 to $3.80. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.